Literature DB >> 19860996

Differential effects of dietary fatty acids on the cerebral distribution of plasma-derived apo B lipoproteins with amyloid-beta.

Ryusuke Takechi1, Susan Galloway, Menuka M S Pallebage-Gamarallage, Cheryl L Wellington, Russell D Johnsen, Satvinder S Dhaliwal, John C L Mamo.   

Abstract

Some dietary fats are a risk factor for Alzheimer's disease (AD) but the mechanisms for this association are presently unknown. In the present study we showed in wild-type mice that chronic ingestion of SFA results in blood-brain barrier (BBB) dysfunction and significant delivery into the brain of plasma proteins, including apo B lipoproteins that are endogenously enriched in amyloid-beta (Abeta). Conversely, the plasma concentration of S100B was used as a marker of brain-to-blood leakage and was found to be increased two-fold because of SFA feeding. Consistent with a deterioration in BBB integrity in SFA-fed mice was a diminished cerebrovascular expression of occludin, an endothelial tight junction protein. In contrast to SFA-fed mice, chronic ingestion of MUFA or PUFA had no detrimental effect on BBB integrity. Utilising highly sensitive three-dimensional immunomicroscopy, we also showed that the cerebral distribution and co-localisation of Abeta with apo B lipoproteins in SFA-fed mice are similar to those found in amyloid precursor protein/presenilin-1 (APP/PS1) amyloid transgenic mice, an established murine model of AD. Moreover, there was a strong positive association of plasma-derived apo B lipoproteins with cerebral Abeta deposits. Collectively, the findings of the present study provide a plausible explanation of how dietary fats may influence AD risk. Ingestion of SFA could enhance peripheral delivery to the brain of circulating lipoprotein-Abeta and exacerbate the amyloidogenic cascade.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19860996     DOI: 10.1017/S0007114509992194

Source DB:  PubMed          Journal:  Br J Nutr        ISSN: 0007-1145            Impact factor:   3.718


  34 in total

1.  Probucol suppresses enterocytic accumulation of amyloid-β induced by saturated fat and cholesterol feeding.

Authors:  Menuka M Pallebage-Gamarallage; Susan Galloway; Ryusuke Takechi; Satvinder Dhaliwal; John C L Mamo
Journal:  Lipids       Date:  2011-07-31       Impact factor: 1.880

Review 2.  Fat sensing and metabolic syndrome.

Authors:  Jang H Youn
Journal:  Rev Endocr Metab Disord       Date:  2014-12       Impact factor: 6.514

3.  Apolipoprotein E does not cross the blood-cerebrospinal fluid barrier, as revealed by an improved technique for sampling CSF from mice.

Authors:  Min Liu; David G Kuhel; Ling Shen; David Y Hui; Stephen C Woods
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2012-08-29       Impact factor: 3.619

4.  Insulin increases central apolipoprotein E levels as revealed by an improved technique for collection of cerebrospinal fluid from rats.

Authors:  Min Liu; Ling Shen; Denovan P Begg; David A D'alessio; Stephen C Woods
Journal:  J Neurosci Methods       Date:  2012-06-09       Impact factor: 2.390

Review 5.  Cognitive Deficits in Type-1 Diabetes: Aspects of Glucose, Cerebrovascular and Amyloid Involvement.

Authors:  Justin Pickering; Rachel Wong; Hani Al-Salami; Virginie Lam; Ryu Takechi
Journal:  Pharm Res       Date:  2021-09-03       Impact factor: 4.200

6.  Amyloid-beta colocalizes with apolipoprotein B in absorptive cells of the small intestine.

Authors:  Susan Galloway; Ryusuke Takechi; Menuka M S Pallebage-Gamarallage; Satvinder S Dhaliwal; John C L Mamo
Journal:  Lipids Health Dis       Date:  2009-10-22       Impact factor: 3.876

7.  Caffeine, Through Adenosine A3 Receptor-Mediated Actions, Suppresses Amyloid-β Protein Precursor Internalization and Amyloid-β Generation.

Authors:  Shanshan Li; Nicholas H Geiger; Mahmoud L Soliman; Liang Hui; Jonathan D Geiger; Xuesong Chen
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

8.  Liver X receptor agonist treatment ameliorates amyloid pathology and memory deficits caused by high-fat diet in APP23 mice.

Authors:  Nicholas F Fitz; Andrea Cronican; Tam Pham; Allison Fogg; Abdul H Fauq; Robert Chapman; Iliya Lefterov; Radosveta Koldamova
Journal:  J Neurosci       Date:  2010-05-19       Impact factor: 6.167

9.  Restoration of dietary-fat induced blood-brain barrier dysfunction by anti-inflammatory lipid-modulating agents.

Authors:  Menuka Pallebage-Gamarallage; Virginie Lam; Ryusuke Takechi; Susan Galloway; Karin Clark; John Mamo
Journal:  Lipids Health Dis       Date:  2012-09-17       Impact factor: 3.876

10.  Nutraceutical agents with anti-inflammatory properties prevent dietary saturated-fat induced disturbances in blood-brain barrier function in wild-type mice.

Authors:  Ryusuke Takechi; Menuka M Pallebage-Gamarallage; Virginie Lam; Corey Giles; John C Mamo
Journal:  J Neuroinflammation       Date:  2013-06-19       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.